Charles Padala | IR |
Dror Bashan | President, CEO & Director |
Eyal Rubin | SVP, CFO, Treasurer & Corporate Secretary |
John Vandermosten | Zacks |
Good morning, ladies and gentlemen, and welcome to the Protalix BioTherapeutics First Quarter 2023 Financial Business Results Conference Call.
As a reminder, this conference is being recorded.
I will now turn the conference over to our host, Mr. Chuck Padala of LifeSci Advisors, Investor Relations for Protalix.
You may now begin.